company info

IO Biosciences

IO Biosciences is a company focused on developing allogeneic, gene modified cell therapies treating cancers. The company leverages a proprietary gene editing system and cell source, creating a unique opportunity to develop and manufacture of-the-shelf gene modified cell therapies.

Founded in 2017 by Sicco H. Popma and Yuta Lee

investors

IO Biosciences

Contact Sicco Popma for investment opportunities

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt